Early diagnosis of congenital hearing impairment is of great importance to later development and social life of the affected newborns. Otoacoustic emission screening test (OAEs) is a useful tool for early evaluation of hearing in neonates and infants. Some specific risk factors (RFs) associated with prenatal, birth and early postnatal periods may influence the first screening results and further diagnostic findings. Results from OAEs in newborns in University Hospital in Pleven between 2013-2015 years are analyzed. In low birth weight children (under 2500 grams or g), and those born before the 36th gestation week (GW), we found deviations in the OAEs. A negative test result proved higher in newborns subjected to oxygen therapy during the first hours after birth (15.5%), as well as in newborns with higher leucocytes count (11.0%) or higher serum bilirubin value immediately after birth. The average birth weight of the newborns was lower in the cases with negative test results (2848.7±506.5 g) and unilateral negative test results (2823.3±535.2 g), as compared with the group with positive test results (3191.9±387.9 g). Elevated bilirubin levels were more frequently established and can be expected with higher probability in low birth weight children. They shall be subject to a follow-up in time, and newborns with initial negative test result shall undergo a second test 2 months after birth. Long term monitoring is recommended for newborns with these risk factors.
2. Mukari SZ, Tan KY, Abdullah A. A pilot project on hospital-based universal newborn hearing screening: Llessons learned. Int J Pediatr Otorhinolaryngol. 2006;70(5):843-51.
3. Coates H, Gifkins K. Diagnostic tests, newborn hearing screening. Aust Prescr. 2003;26(4):82-4.
4. Cunningham M, Cox EO. Committee on Practice and Ambulatory Medicine and the Section on Otolaryngology and Bronchoesophagology. Hearing assessment in infants and children: recommendations beyond neonatal screening. Pediatrics. 2003;111(2):436-40.
5. Cristobal R, Oghalai JS. Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):F462-8.
6. Finitzo T, Albright K, O’Neal J. The newborn with hearing loss: detection in the nursery. Pediatrics. 1998;102(6):1452-60.
7. Lima GM, Marba ST, Santos MF. Hearing screening in neonatal intensive care unit. Pediatric (Rio J) 2006;82(2):110-4.
8. Bielecki I, Horbulewicz A, Wolan T. Prevalence and risk factors for auditory neuropathy spectrum disorder in a screened newborn population at risk for hearing loss. Int J Pediatr Otorhinolaryngol. 2012;76(11):1668-70.
13. Olusanya BO, Wirz SL, Luxon LM. Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study. Bull World Health Organ. 2008;86(12):956-63.
14. Yousefi J, Ajalloueyan M, Amirsalari S, Hassanali Fard M. The specificity and sensitivity of transient otoacustic emission in neonatal hearing screening compared with diagnostic test of auditory brain stem response in tehran hospitals; Iran J Pediatr. 2013;23(2):199-204.
15. Ari-Even Roth D, Hildesheimer M, Maayan-Metzger A, Muchnik C, Hamburger A, Mazkeret R, et al. Low prevalence of hearing impairment among very low birthweight infants as detected by universal neonatal hearing screening. Arch Dis Child Fetal Neonatal Ed. 2006 Jul;91(4):F257-62.
16. Todorova Y, Valkov A, ,Duhlenski B, Nikolov G, Atanasova K ,Elkina S. et al. [Use of Shoe Box iPad iOS – based play audiometry as a hearing impairment screening tool for preschool children]. Pediatry. .2017;50(1)41-5. Bulgarian.